Family Medicine
Monkeypox (hMPXV infection): a practical review
11 Jan, 2023 | 14:25h | UTCMonkeypox (hMPXV infection): A practical review – American Journal of Medicine
SR | Efficacy of presurgical interventions to promote smoking cessation
11 Jan, 2023 | 14:24h | UTC
Guideline | Hearing loss in children
11 Jan, 2023 | 14:16h | UTC
Guideline Synopsis | Diabetes management in chronic kidney disease
10 Jan, 2023 | 14:52h | UTCCommentary: Layered Approach Recommended for Patients With Diabetes, CKD – HealthDay
Original Guideline: KDIGO 2022 Clinical practice guideline for diabetes management in chronic kidney disease.
AAP Guideline | Evaluation and treatment of children and adolescents with obesity
10 Jan, 2023 | 14:54h | UTCExecutive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity – Pediatrics
Commentaries:
Childhood obesity requires early, aggressive treatment, new guidelines say – NPR
New guidance: Use drugs, surgery early for obesity in kids – Associated Press
RCT | Effect of prescriber notifications of patient’s fatal overdose on opioid prescribing at 4 to 12 months
10 Jan, 2023 | 14:50h | UTC
Commentary on Twitter
Letters notifying clinicians of a patient's fatal overdose reduced opioid prescribing up to one year after receiving the letter. https://t.co/cEU1inH9lE
— JAMA Network Open (@JAMANetworkOpen) January 6, 2023
Diagnostic accuracy study | Home waking salivary cortisone to screen for adrenal insufficiency
10 Jan, 2023 | 14:47h | UTCHome Waking Salivary Cortisone to Screen for Adrenal Insufficiency – NEJM Evidence
Commentary: At-home saliva test to diagnose adrenal insufficiency makes a difference to patients’ health – News Medical
Commentary on Twitter
This prospective study tested use of home waking salivary cortisone levels to predict adrenal insufficiency. Salivary cortisone had diagnostic accuracy similar to that of a standard adrenocorticotropin (ACTH) stimulation test. https://t.co/EYEBppBN7y#EndoTwitter #MedTwitter pic.twitter.com/RsKvnCHrUQ
— NEJM Evidence (@NEJMEvidence) January 6, 2023
M-A | Association of hearing aids and cochlear implants with cognitive decline and dementia
10 Jan, 2023 | 14:43h | UTCAssociation of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis – JAMA Neurology (link to abstract – $ for full-text)
Commentary: Review Links Hearing Aid Devices With Reduced Cognitive Decline – HealthDay
Related: Dementia and hearing-aid use: a two-way street – Age and Ageing
WHO Interim Guidance | Surveillance, case investigation and contact tracing for mpox (monkeypox)
10 Jan, 2023 | 14:45h | UTC
Dementia and hearing-aid use: a two-way street
10 Jan, 2023 | 14:42h | UTCDementia and hearing-aid use: a two-way street – Age and Ageing
Related: Association of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis – JAMA Neurology (link to abstract – $ for full-text)
M-A | Prospective association of daily steps with cardiovascular disease
10 Jan, 2023 | 14:29h | UTCProspective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-Analysis – Circulation (link to abstract – $ for full-text)
Commentaries:
CVD Benefits of Activity Seen Below Widely Quoted Step Goal in Older Adults – TCTMD
Heart health tip for older adults in 2023: Step it up a bit – University of Massachusetts Amherst
Commentary on Twitter
#OriginalResearch: In a meta-analysis of 8 studies, 6,000 to 9,000 steps/day was associated with 40% to 50% lower risk of CVD among older adults #AHAJournals https://t.co/fEA1EFyhTI pic.twitter.com/T6LXFGZoVb
— Circulation (@CircAHA) December 21, 2022
Podcast | Diagnosis and management of ADHD in adults
10 Jan, 2023 | 14:31h | UTC#374 ADHD with Dr. Kevin Simon – The Curbsiders
SR | No-test medication abortion
10 Jan, 2023 | 14:02h | UTCNo-Test Medication Abortion: A Systematic Review – Obstetrics & Gynecology
Commentary on Twitter
From Shapiro et al: medication abortion performed without prior pelvic exam or ultrasound is safe and effective. #free #podcast https://t.co/xightukWW0 pic.twitter.com/P6bajuKZDU
— The Green Journal (@greenjrnl) December 21, 2022
Atypical ulcers: a stepwise approach for clinicians
10 Jan, 2023 | 14:00h | UTCAtypical Ulcers: A Stepwise Approach for Clinicians – Wounds
ACP Guideline | Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults
9 Jan, 2023 | 14:59h | UTCSummary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults
WHO updates recommendations on HPV vaccination schedule
9 Jan, 2023 | 14:57h | UTCNews Release: WHO updates recommendations on HPV vaccination schedule – World Health Organization
Guideline: Human papillomavirus vaccines: WHO position paper, December 2022 – World Health Organization
Commentaries:
WHO supports 1-dose HPV vaccine strategy – CIDRAP
Commentary on Twitter
🆕 WHO has revised its recommendations on possible schedules for human papillomavirus (#HPV) vaccines & now recommends:
👉1 or 2-doses for girls & women aged 9-20
👉2 doses with a 6-month interval for women 21+https://t.co/m0KZyH6sPR pic.twitter.com/W4PeS4raV9— World Health Organization (WHO) (@WHO) December 21, 2022
WHO | Increase in invasive Group A streptococcal infections among children in Europe, including fatalities
9 Jan, 2023 | 14:53h | UTC
RCT | VV116 vs. Nirmatrelvir–Ritonavir for oral treatment of Covid-19
9 Jan, 2023 | 14:50h | UTCVV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 – New England Journal of Medicine
Commentaries:
Study could pave way for new antiviral, as China grapples with Covid wave – STAT
Chinese oral COVID-19 drug equally effective with Paxlovid: study
VV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19 – HealthDay
Commentary on Twitter
In a Chinese trial involving participants with symptomatic mild-to-moderate Covid-19, VV116 (an oral analogue of remdesivir) was noninferior to nirmatrelvir–ritonavir with respect to the time to sustained clinical recovery.
Read the full study: https://t.co/zckTB3Rvb9 pic.twitter.com/0TVF7hEXjP
— NEJM (@NEJM) December 28, 2022
Consensus Guideline | Management of the perioperative patient on cannabis and cannabinoids
9 Jan, 2023 | 14:43h | UTC
Commentary on Twitter
https://twitter.com/ASRA_Society/status/1610269709374554114
M-A | Physical activity interventions to alleviate depressive symptoms in children and adolescents
9 Jan, 2023 | 14:37h | UTCPhysical Activity Interventions to Alleviate Depressive Symptoms in Children and Adolescents: A Systematic Review and Meta-analysis – JAMA Pediatrics (link to abstract – $ for full-text)
Commentary: Exercise, Sports: A Natural Antidepressant for Teens – HealthDay
Commentary on Twitter
The results of this systematic review and meta-analysis suggest that physical activity interventions can alleviate symptoms of depression in children and adolescents. https://t.co/7P6gWPf35K
— JAMA Pediatrics (@JAMAPediatrics) January 3, 2023
RCT | Chlorthalidone (12.5-25 mg) and Hydrochlorothiazide (25-50 mg) are similarly effective for the prevention of CVD in hypertensive patients.
16 Dec, 2022 | 13:49h | UTCChlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events – New England Journal of Medicine (link to abstract – $ for full-text)
Related (news release and commentaries before publication): RCT | Chlortalidone and Hydrochlorothiazide resulted in similar reductions of CVD in older patients with hypertension.
Commentary on Twitter
Patients 65 years or older with hypertension who switched from chlorthalidone to hydrochlorothiazide did not have fewer major cardiovascular events or non–cancer-related deaths than those who continued receiving hydrochlorothiazide. https://t.co/9xAiSZzxio pic.twitter.com/bIVOOiVDve
— NEJM (@NEJM) December 14, 2022
Updated Guidance | Acute, periprocedural and long-term antithrombotic therapy in older adults.
16 Dec, 2022 | 13:51h | UTCCommentary: Antithrombotic Therapy in Older Adults: Key Points – American College of Cardiology
Cohort Study | Association between bariatric surgery and alcohol use–related hospitalization and all-cause mortality.
16 Dec, 2022 | 13:44h | UTCAssociation Between Bariatric Surgery and Alcohol Use–Related Hospitalization and All-Cause Mortality in a Veterans Affairs Cohort – JAMA Surgery (link to abstract – $ for full-text)
RCT | Effect of an intermittent calorie-restricted diet on Type 2 DM remission.
16 Dec, 2022 | 13:43h | UTCEffect of an Intermittent Calorie-restricted Diet on Type 2 Diabetes Remission: A Randomized Controlled Trial – The Journal of Clinical Endocrinology & Metabolism (link to abstract – $ for full-text)
Commentaries:
Expert reaction to study looking at intermittent fasting and type 2 diabetes – Science Media Centre
Intermittent Fasting Can Achieve Remission in Type 2 Diabetes – HealthDay
Commentary on Twitter
Can an intermittent fasting (IF) diet reverse Type 2 diabetes?
A small randomized trial says yes, w/ 47% of IF-assigned participants achieving remission for at least 1 year vs 3% of controls (odds ratio of 31; yes, too good to be true)https://t.co/Ths3LrNL8u
Worth further study pic.twitter.com/VwOqMeAAJr— Eric Topol (@EricTopol) December 14, 2022
Guideline | ADA 2023 Standards of Medical Care in Diabetes.
14 Dec, 2022 | 15:59h | UTCGuideline Homepage: ADA 2023 Standards of Medical Care in Diabetes – American Diabetes Association
Introduction: Standards of Medical Care in Diabetes—2023
Summary of Revisions: Standards of Medical Care in Diabetes—2023
- Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2023
- Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
- Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
- Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
- Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023
- Glycemic Targets: Standards of Care in Diabetes—2023
- Diabetes Technology: Standards of Care in Diabetes—2023
- Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023
- Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
- Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
- Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
- Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2023
- Older Adults: Standards of Care in Diabetes—2023
- Children and Adolescents: Standards of Care in Diabetes—2023
- Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2023
- Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
- Diabetes Advocacy: Standards of Care in Diabetes—2023


